Recently, at the "National Workers' Cancer Prevention and Control Promotion Special Project and Alliance Establishment" conference held in Beijing, the group standard "Technical Service Specification for Common Cancer Screening for Workers" was officially approved and is scheduled to be officially released on September 1, 2023.
As the first cancer screening service standard for workers in China, the Specification clearly states that cancer screening is mainly carried out for nine common preventable and controllable cancers (lung cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, female breast cancer cancer, cervical cancer, thyroid adenocarcinoma, male prostate cancer) in Chinese population.
As a biotechnology enterprise driven by innovative technology, Linaxin Biotechnology focuses on early screening of high-risk cancers. Its colorectal cancer early screening series products adopt advanced genetic testing technology and biomarker analysis, which can provide convenient screening services for workers.
Laborers are the backbone of social development, and they make tremendous contributions to family happiness and national construction with their sweat and wisdom. However, the fast-paced lifestyle and workplace pressure pose significant challenges to the health of workers.
The image is sourced from the internet
Wang Xiao, Chairman of the Workers' Health Management Committee of the China Occupational Safety and Health Association, introduced that in recent years, cancer patients in China are showing a trend of younger age. According to data from 2021, there were approximately 2.369 million new cancer cases among the 25-64 age group in China in 2020, accounting for 51.8% of all new cancer cases. There is an urgent need for scientific cancer prevention and screening.
The image is sourced from the internet
Wang Siyang, Secretary General of the Workers' Health Management Committee, introduced that the "National Workers' Cancer Prevention and Control Promotion Special Project" will promote the construction of 1000 national workers' cancer prevention and control promotion special practice demonstration alliance institutions, and complete the "3+2" enterprise cancer prevention and control promotion special work of "3 to carry out 2 tracking". This includes promoting standardized cancer screening services for workers, optimizing enterprise cancer prevention physical examination plans, establishing positive indicator follow-up and intervention management, and setting up expert consultants to track and guide early diagnosis and treatment intervention results.
The image is sourced from the internet
The "Regulations" provide normative guidelines for the inclusion of high-risk populations, cancer screening techniques and plans, cancer screening result management and follow-up, etc. Among them, it is recommended to conduct colorectal cancer screening for high-risk individuals and general risk individuals aged 50-70 for colorectal cancer. In terms of screening technology selection, in addition to traditional colonoscopy and fecal occult blood test, it is also recommended to use fecal DNA testing technology.
Linaxin launches "Enterprise Group Inspection" cancer prevention testing service
To safeguard the health of workers
In China, the incidence rate of colorectal cancer ranked fifth in 2015. By 2020, colorectal cancer has risen to the second highest incidence of cancer. On average, one person was diagnosed with colorectal cancer within 1.3 minutes, and 85% of patients were found to be in the middle and late stages, bringing huge economic and disease burden.
Smoking, drinking alcohol, irregular diet, high work pressure, and frequent staying up late can all increase the risk of colon cancer. For the sake of one's own physical health, it is best to try to smoke and drink less, eat on time, relax appropriately to make oneself physically and mentally happy, and go to bed before 10 o'clock.
Linaxin has launched a heavyweight "colorectal cancer early screening" enterprise group testing service for enterprise employees, using DNA methylation testing technology to provide comprehensive health management services covering prevention, screening, diagnosis and treatment throughout the entire cycle, improving the possibility of early detection of tumors and effectively enhancing employees' happiness and sense of achievement.
Linaxin's "Early Screening for Colorectal Cancer" only requires collecting samples at home, making online appointments for express delivery and testing, obtaining reports on mobile phones, painless and non-invasive, efficient and fast, reducing the pressure and time cost of employees seeking medical treatment outside, providing efficient, scientific, non-invasive and convenient colorectal cancer auxiliary diagnosis for workers, and easily preventing cancer at home.
Good news! Linaxin was successfully selected as th...2024-09-26
Good news! Linaxin joint application for provincia...2024-07-01
Linaxin makes its debut at the 89th China Internat...2024-04-22
Seize the opportunity and shine together for the f...2024-01-02
Linaxin collaborates with Yinan County Charity Fed...2023-12-13
WeChat service account
400-611-8890
linaxin@linaxin.cn
Room 501, Building 3, Huaqiao International Innovation Port, No. 15 Jinyang Road, Huaqiao Town, Kunshan, Suzhou City, Jiangsu Province
COPYRIGHT (©) 2022 Suzhou Linaxin Biotechnology Co., Ltd
Su ICP NO.20022051-1
